Cincinnati startup key player in $330M Blackstone-backed drug collaboration

"This is something that has the potential to replace most IV therapy — and that, to me, is one of the biggest disruptions that I've ever seen in health care.”
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.